Amarin Corp Plc (AMRN)

[bidmark]

But what if we wait until 2016 and....

Reduce-It fails to produce the results or the FDA finds some reason to reject them (assuming interim results haven't already done the same thing)? There obviously is a serious trust issue with management at this point and I think they'll have a hard time convincing anyone (shareholders, BOD, potential partners or buyout companies) that they actually have a valuable project. I don't mind sitting on shares until 2016, but I need to be convinced that it will be worth the wait!